Search clinical trials for: Immunogenicity

Total 3457 results

Institut Claudius Regaud

Recruiting

Deciphering Mechanisms Underlying Cancer Immunogenicity (DECIDE)

Cervical Cancer | Head and Neck Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Anal Cancer | Cervical Intraepithelial Neoplasia 3 | Glioblastoma Multiforme of Brain Stem

France
Amicus Therapeutics

Recruiting

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

Pompe Disease (Late-onset)

United States, Japan, Australia, Taiwan, Canada
International Centre for Diarrhoeal Disease Research...
World Health Organization

Recruiting

Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh

Poliomyelitis

Bangladesh
National Institute of Allergy and Infectious Diseases...

Recruiting

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

Healthy Volunteer

United States
Herbert Lyerly

Recruiting

Assessing the Immunogenicity of pING-hHER3FL

Advanced Cancer

United States
U.S. Army Medical Research and Development Command

Recruiting

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children

RSV Infection

United States
International Centre for Diarrhoeal Disease Research...
Stanford University; Centers for Disease Control and Prevention

Recruiting

Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera Vaccine

Vaccine Reaction

Bangladesh
U.S. Army Medical Research and Development Command

Not yet recruiting

Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults (VEE)

Venezuelan Equine Encephalomyelitis

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Idiopathic CD4 T Cell Lymphocytopenia

United States
Sanaria Inc.
Indonesia University; Congressionally Directed Medical Research Programs; Eijkman...

Recruiting

Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria

Malaria

Indonesia
ModernaTX, Inc.
Merck Sharp & Dohme LLC

Recruiting

Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors (KEYNOTE-603)

Solid Tumors

United States, Australia
medac GmbH
Syneos Health

Recruiting

PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia

Acute B-Cell Lymphoblastic Leukaemia

Brazil
Oswaldo Cruz Foundation

Recruiting

Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals (YF-HIV)

HIV Infections

Brazil
National Institute of Allergy and Infectious Diseases...

Suspended

Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)

Malaria

Mali
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure

Healthy Volunteers

United States
Mabscale, LLC

Active, not recruiting

Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation
BioNTech SE
Pfizer

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

COVID-19 | Influenza

United States
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Enrolling by invitation

Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines

Varicella

Philippines
ModernaTX, Inc.

Active, not recruiting

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

Norovirus Acute Gastroenteritis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

Meningococcal Infections

Czechia, Finland, Italy, Poland, Romania, Spain, Sweden
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity

Breast Cancer

United States
Centers for Disease Control and Prevention
Ministry of Health, Thailand

Completed

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

Influenza

Thailand
BioNTech SE
Pfizer

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

COVID-19 | Influenza, Human

United States
National Institute of Allergy and Infectious Diseases...
Gritstone bio, Inc.

Completed

Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults

COVID-19

United States
AstraZeneca

Active, not recruiting

MEDI5752 in Japanese Patients With Advanced Solid Tumors.

Advanced Solid Tumors

Japan
National Institute of Allergy and Infectious Diseases...

Completed

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects

Rabies | Rabies Immunisation

United States
Biogen

Terminated

Natalizumab Subcutaneous Immunogenicity and Safety Study (SIMPLIFY)

Relapsing Multiple Sclerosis

Belgium
Zhejiang Echon Biopharm Limited

Active, not recruiting

Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects

Healthy

China
Teva takeda

Active, not recruiting

Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children (TIDES)

Healthy Volunteers

Thailand, Brazil, Colombia, Dominican Republic, Nicaragua, Panama, Philippines, Sri Lanka
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

COVID-19

China
GlaxoSmithKline

Active, not recruiting

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

Influenza, Human

United States
Centers for Disease Control and Prevention
San Lucas Hospital, Ponce, Puerto Rico

Completed

Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine

Poliomyelitis

Puerto Rico
Duke University
Washington University School of Medicine; University of Pittsburgh; Centers for... and other collaborators

Completed

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

COVID-19 | Influenza

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Safety and Immunogenicity of CJCV2 With and Without ALFQ

Campylobacter Infection

United States
National Institute of Allergy and Infectious Diseases...
Ina-Respond; Institut National de Recherche Biomédicale. Kinshasa, République... and other collaborators

Active, not recruiting

International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE) (InVITE)

COVID-19

Congo, The Democratic Republic of the, Guinea, Indonesia, Liberia, Mali, Mexico, Mongolia
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V116 in Vaccine-naïve Japanese Older Adults (V116-009, STRIDE-9)

Pneumococcal Disease

Japan
Novavax

Completed

A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. (COVID-19)

COVID-19

United States
Centers for Disease Control and Prevention
Mayo Clinic; Baylor College of Medicine; University of Alabama at Birmingham; Emory... and other collaborators

Completed

Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change (AVRP)

Healthy

United States
Pfizer

Active, not recruiting

A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan

Pneumococcal Disease

Taiwan, India
Minervax ApS
Iqvia Pty Ltd

Completed

Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants

Group B Streptococcal Infections

Belgium
University of Peshawar
Hayatabad Medical Complex

Completed

Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally

Rabies

Pakistan
Seqirus

Active, not recruiting

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Quadrivalent Influenza Vaccine Compared to a Non-adjuvanted Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age

Influenza, Human

Turkey, Belgium, Bulgaria, Czechia, Finland, Georgia, Italy, Korea, Republic of, Lithuania, Netherlands, Poland, Romania, Spain, Taiwan
Health Institutes of Turkey

Completed

Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent

COVID-19 | Sars-CoV-2 Infection

Turkey
University of Witwatersrand, South Africa

Completed

Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children (PCV1+1_FU)

Pneumonia | Meningitis

South Africa
Seqirus

Active, not recruiting

Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying mRNA Influenza Vaccine in Healthy Adults

Influenza, Human

Australia
Sinovac Biotech Co., Ltd
Pontificia Universidad Catolica de Chile; Sinovac Biotech Co., Ltd

Completed

Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Seasonal Influenza

Philippines, Chile
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Lot Consistency of V116 in Adults 18 to 49 Years of Age (V116-004, STRIDE-4)

Pneumococcal Disease

United States, Austria, Canada, Denmark, Finland, Israel, Poland, Spain
Health Institutes of Turkey

Completed

Observational National Vaccine Study

COVID-19 Infection

Turkey
PharmaJet, Inc.
National Cancer Institute (NCI); National Institutes of Health (NIH)

Withdrawn

Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System

Vaccine Reaction

Indonesia

3

Subscribe